Skip to product information
1 of 1

NSJ Bioreagents

SKU:N1046-25UG

Als2Cr2 Antibody / STRADB / ILPIP

Als2Cr2 Antibody / STRADB / ILPIP

Regular price $225.00 USD
Regular price Sale price $225.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

Als2Cr2, also called STE20-related kinase adapter protein beta (STRAD beta) and ILPIP, is a serine/threonine protein kinase encoded by the STRADB gene, discovered as an XIAP interacting protein. It is a mediator of the XIAP/TAK1 activation of the JNK1 pathway, an apoptosis inhibition mechanism independent of XIAP inhibition of caspases. Alone, it only moderately activates JNKs, but its interaction with XIAP/TAK1 induces a much stronger activation of JNK1, protecting against Caspase 1- or Fas-induced apoptosis.

Specifications

Family Primary antibody
Formulation 0.5 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Format Purified
Host Animal Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit IgG
Species Reactivity Human, Mouse, Rat
Application WB
Application Details Western blot: 5-10ug/ml
Application Note Provided assay concentrations are suggestions only, Als2Cr2 antibody titration may be required for optimal results. This antibody will detect the 418 (ILPIP alpha) and 280 (ILPIP beta) amino acid isoforms.
Immunogen A recombinant protein fragment from the interior region of human Als2Cr2 was used as the immunogen for this antibody.
Buffer 1X PBS, pH 7.4
Purity Protein A affinity chromatography
Storage Aliquot the Als2Cr2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This Als2Cr2 antibody is available for research use only.
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/als2cr2-antibody-stradb-ilpip-n1046
Title Als2Cr2 Antibody / STRADB / ILPIP
Description Als2Cr2, also called STE20-related kinase adapter protein beta (STRAD beta) and ILPIP, is a serine/threonine protein kinase encoded by the STRADB gene, discovered as an XIAP interacting protein. It is a mediator of the XIAP/TAK1 activation of the JNK1 pathway, an apoptosis inhibition mechanism independent of XIAP inhibition of caspases. Alone, it only moderately activates JNKs, but its interaction with XIAP/TAK1 induces a much stronger activation of JNK1, protecting against Caspase 1- or Fas-induced apoptosis.
View full details